406 related articles for article (PubMed ID: 10799863)
1. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
2. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
4. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
López D; Del Val M
J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
[TBL] [Abstract][Full Text] [Related]
5. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
6. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
7. TAP-independent presentation of CTL epitopes by Trojan antigens.
Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
[TBL] [Abstract][Full Text] [Related]
8. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
[TBL] [Abstract][Full Text] [Related]
9. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
[TBL] [Abstract][Full Text] [Related]
12. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.
Gil-Torregrosa BC; Raúl Castaño A; Del Val M
J Exp Med; 1998 Sep; 188(6):1105-16. PubMed ID: 9743529
[TBL] [Abstract][Full Text] [Related]
14. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
15. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
16. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
Yang B; Hahn YS; Hahn CS; Braciale TJ
J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
[TBL] [Abstract][Full Text] [Related]
17. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
[TBL] [Abstract][Full Text] [Related]
18. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
[TBL] [Abstract][Full Text] [Related]
19. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
Sijts AJ; Standera S; Toes RE; Ruppert T; Beekman NJ; van Veelen PA; Ossendorp FA; Melief CJ; Kloetzel PM
J Immunol; 2000 May; 164(9):4500-6. PubMed ID: 10779750
[TBL] [Abstract][Full Text] [Related]
20. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.
Niedermann G; Geier E; Lucchiari-Hartz M; Hitziger N; Ramsperger A; Eichmann K
Immunol Rev; 1999 Dec; 172():29-48. PubMed ID: 10631935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
